Miliary osteosarcomatosis with associated hypocalcemia

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 5, 1997, Pages 505-508

  Chap, Linnea I ^a,d   Mirra, Joseph ^b   Ippolito, Vincenzo ^b   Rentschler, Robert ^c   Rosen, Peter ^a  

^a UCLA MEDICAL CENTER   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

^c Beaver Medical Clinic   (United States)

^d Division of Hematoloay/Oncoloay   (United States)

Author keywords

Hypocalcemia; Multicentric; Multifocal; Osteogenic sarcoma; Osteosarcomatosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CISPLATIN; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LACTATE DEHYDROGENASE; MESNA; PARATHYROID HORMONE; VITAMIN D;

ADULT; ARTICLE; BONE SCINTISCANNING; CALCIUM BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE CANCER; ORAL DRUG ADMINISTRATION; OSTEOSARCOMA; PARESTHESIA; PELVIS RADIOGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION; TETANY;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CISPLATIN; DOXORUBICIN; EXPECTORANTS; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; HYPOCALCEMIA; IFOSFAMIDE; LUNG NEOPLASMS; MESNA; OSTEOSARCOMA;

EID: 0030810882     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199710000-00014     Document Type: Article

References (14)

1. Mirra JM, Gold RH, Picci PP. Clinical, radiologie and pathologie correlations. Philadelphia: Lea & Febiger, 1989:301-8.
2. Mahoney JP, Spanier SS, Morris JL. Multifocal osterosarcoma: a case report with review of the literature. Cancer 1979; 44:1897-907.
3. Amstutz HC. Multiple osteogenic sarcomata: metastatic or multicentric? Report of two cases and review of the literature. Cancer 1969;24:923-31.
4. Hopper KD, Moser RP, Haseman DB. Osteosarcomatosis. Radiology 1990; 175:233-9.
5. Batson OV. The vertebral vein system. Am J Radial 1957; 78:195-212.
6. Ippolito V, Mirra JM, Fedenko A. Case report 827: miliary osteosarcomatosis. Skel Radial 1994;23:143-7.
7. Eilber FR, Rosen G. Adjuvant chemotherapy for osteosarcoma. Semin Oncol 1989; 16:312-23.
8. Bowman LC, Meyer WN, Douglas EC. Activity of ifosfamide in metastatic and unresectable osteosarcoma [Abstract A844]. ProcAm Soc Clin Oncol 1987;6:214.
9. Meyer WH, Pratt CB, Parham D. The activity of ifosfamide in previously untreated patients with osteosarcoma: Preliminary results of SJCRH 05-86 Study [Abstract A1011]. Proc Am Soc Clin Oncol 1988;7:261.
10. Mosende C, Gutierrez M, Capparos B. Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of metastatic osteosarcoma. Cancer 1977; 40:2779-86.
11. Ludwig JD. Hypocalcemia and hypophosphatemia accompanying osteoblastic osseous métastases: studies of calcium and phosphate metabolism and parathyroid function. Ann Intern Med 1962;56:676-7.
12. Sackner MA, Spivack AP, Balian IJ. Hypocalcemia in the presence of osteoblastic métastases. N Engl J Med 1960; 262:1736.
13. Riancho JA, Arjona R, Valle R. The clinical spectrum of hypocalcemia associated with bone métastases. J Intern Med 1989;226:449-52.
14. Spencer H, Eisenger R, Laszlo D. Metabolic and radioactive tracer studies in carcinoma of prostate. Am J Med 1960;29:282-96.